CT angiography (CTA) is one of the most reliable noninvasive tools for detecting arterial blockages, with an overall accuracy around 88% when compared to traditional catheter-based angiography. It works by injecting a contrast dye into your bloodstream and using rapid CT scanning to create detailed 3D images of your arteries, revealing where blood flow is narrowed or blocked. For many people with suspected heart disease, it’s the first imaging test ordered.
How CTA Makes Blockages Visible
The core principle is straightforward: an iodine-based contrast dye is injected into a vein, usually in your arm. As the dye flows through your arteries, it lights up the inside of the vessels on the CT scanner, creating a sharp contrast between flowing blood and the vessel walls. This allows radiologists to see exactly where plaque has built up and how much it’s narrowing the artery.
CTA doesn’t just show whether a blockage exists. It can characterize the size, shape, and severity of the narrowing. It can also distinguish between different types of plaque, including early-stage fatty deposits and harder calcified buildup. That distinction matters because softer plaques are more likely to rupture and cause a heart attack, even if they aren’t severely narrowing the artery yet.
Accuracy for Coronary Artery Blockages
When researchers compare CTA results against invasive catheter angiography (the gold standard), the numbers are strong but not perfect. For detecting blockages of 70% or greater in the coronary arteries, CTA has a sensitivity of about 81% and a specificity of 92%. In practical terms, that means it correctly identifies most significant blockages and rarely flags a healthy artery as blocked.
The accuracy varies somewhat depending on which coronary artery is being evaluated. CTA performs best on the right coronary artery, with 80% sensitivity and nearly 99% specificity. It’s somewhat less reliable for the left circumflex artery, where sensitivity drops to around 64%. These differences come down to vessel size, position, and how much the heart’s motion affects the image.
Where CTA truly excels is in ruling blockages out. Its negative predictive value, the likelihood that a normal-looking scan means you truly don’t have a significant blockage, reaches about 90% for severe coronary narrowing. This makes it especially useful as a first-line test: if CTA says your arteries look clear, there’s a high probability they are.
Blockages Beyond the Heart
CTA isn’t limited to coronary arteries. It’s widely used to evaluate the carotid arteries in the neck, which supply blood to the brain and are a major factor in stroke risk. For detecting severe carotid stenosis (70% narrowing or more), CTA has a sensitivity of 88% and specificity of 92%, with a negative predictive value of 98%. It can also screen for moderate narrowing in the 50% to 69% range, though sensitivity is slightly lower at 75%.
The technology also evaluates blockages in the aorta, renal arteries, and peripheral arteries in the legs. For bypass grafts in patients who’ve had previous heart surgery, CTA and catheter angiography show excellent agreement, with one study finding 100% sensitivity and specificity for graft blockages.
Where CTA Has Trouble
Heavy calcium deposits in artery walls are CTA’s biggest challenge. Calcified plaque creates a “blooming artifact” on the scan, essentially a bright halo that makes the calcium look larger than it actually is. This can make a moderate blockage appear severe, or obscure the view of the artery’s interior altogether. Research has shown that adjusting the scanner’s energy settings doesn’t reliably reduce this artifact, so it remains a genuine limitation.
Patients with very high calcium scores (common in older adults and people with longstanding diabetes) may get less reliable results. In these cases, the specificity of CTA tends to drop, meaning more false alarms. When calcium scores are zero, CTA achieves 100% specificity for ruling out severe blockages. As calcium increases, that number falls, reaching around 67% in the highest calcium category. For patients with extensive calcification, catheter-based angiography may still be necessary to get a definitive answer.
Previously placed coronary stents also pose problems. Metal stents cause their own artifacts that can obscure the view inside the stent, making it difficult to determine whether the stent has re-narrowed. Newer photon-counting CT scanners are changing this picture, achieving resolution down to 0.11 mm and demonstrating 100% sensitivity for detecting blockages inside stents in early studies. This technology is not yet widely available but represents a significant step forward.
What the Scan Is Like
A coronary CTA requires your heart rate to be below 65 beats per minute for clear images, since the scanner needs to capture your heart between beats. If your resting heart rate is higher than that, you’ll be given a medication to slow it down before the scan. You’ll also receive a small dose of nitroglycerin spray to widen your coronary arteries for better visualization.
The actual scan takes only a few seconds of breath-holding, though the entire appointment, including IV placement, contrast injection, and preparation, typically runs 30 to 60 minutes. The contrast dye can cause a brief warm flushing sensation and a metallic taste, both of which pass quickly.
Radiation exposure from a coronary CTA averages around 16 millisieverts, though modern scanners and dose-reduction techniques can push this lower. For context, the FDA notes that diagnostic CT procedures generally fall in the 1 to 10 millisievert range, with coronary CTA on the higher end because of the need for rapid, high-resolution cardiac imaging.
Who Should and Shouldn’t Get One
CTA is most valuable for people with intermediate risk of coronary artery disease: those with chest pain or other symptoms where heart disease is possible but not certain. It’s less useful for people already known to have severe disease (where catheter angiography is likely needed anyway) or for very low-risk individuals where the test is unlikely to find anything.
The contrast dye requires adequate kidney function. The key threshold is an estimated glomerular filtration rate (eGFR) below 30, which indicates significantly reduced kidney function. Below that level, the contrast can cause kidney injury. Patients in this range may need extra hydration before and after the scan, or an alternative test entirely. Most people will have blood work checked beforehand to confirm their kidneys can handle the dye.
Allergies to iodine-based contrast are another consideration. If you’ve had a prior reaction, your medical team can premedicate you to reduce the risk, or recommend a different imaging approach.